Latest News Releases From The Newsroom
Flowers Foods Adjusts Outlook, Cavco Industries Surpasses Expectations, OncoSec Medical Closes Offering
May 18th, 2023
Flowers Foods, Inc. (NYSE: FLO) has reported adjusted earnings per share (EPS) of $0.38 for the first quarter of fiscal 2023, meeting the consensus estimate. However, due to a slow start to the year and lower-than-expected branded retail sales result. Read more
Ross Stores Exceeds Q1 Expectations, Pfizer's RSV Vaccine Candidate Gains FDA Committee Support, Lucy Scientific Partners with TheraPsil for Psilocybin Access
May 18th, 2023
Ross Stores, Inc. (Nasdaq: ROST) has reported first-quarter fiscal 2023 earnings per share (EPS) of $1.09, surpassing the consensus estimate of $1.06. However, in after-hours trading, $ROST is experiencing a slight decline, currently trading at $105.. Read more
Financial Snapshot: Farfetch Surpasses Expectations, DXC Technology Faces After-Hours Decline, Globant Falls Short, Applied Materials Exceeds Estimates
May 18th, 2023
In the latest financial reports, Farfetch Limited (NYSE: FTCH) announced an adjusted loss of $0.16 per share for the first quarter of 2023, surpassing the consensus estimate of a loss of $0.42 per share. As a result, $FTCH's after-hours trading shows. Read more
FTC Warns About Misuses of Biometric Information and Harm to Consumers
May 18th, 2023
Agency issues policy statement addressing emerging technologies that might harm consumers and violate the FTC Act Washington D.C. / CRWE PRESS RELEASE / May 18, 2023 - The Federal Trade Commission today issued a warning that the increasi. Read more
FTC Proposes Amendments to Strengthen and Modernize the Health Breach Notification Rule
May 18th, 2023
Proposed changes would underscore the rule’s applicability to health apps and other evolving technologies Washington D.C. / CRWE PRESS RELEASE / May 18, 2023 - The Federal Trade Commission is seeking comment on proposed changes to . Read more
Major Advancements in Biotech: Enveric Biosciences' Psilocin Prodrug Patent Allowance, Phio Pharma's Breakthrough in Cancer Therapy, and Teva's Strategic Framework
May 18th, 2023
Enveric Biosciences, Inc. (Nasdaq: ENVB) has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application related to their new chemical entity (NCE) psilocin prodrug, known as EB-373. This prodrug. Read more
Monro Falls Short of Q4 Expectations as Micron Technology, Mullen Automotive, and FibroGen Make Positive Pre-Market Moves
May 18th, 2023
Monro, Inc. (Nasdaq: MNRO) has released its financial results for the fourth quarter of fiscal 2023, reporting adjusted earnings per share (EPS) that fell short of market expectations. The company's adjusted EPS for the quarter stood at $0.08, compar. Read more
Initiated with a Buy: Arcellx, Pliant Therapeutics, Tarsus Pharmaceuticals, Varonis Systems
May 18th, 2023
Several companies have recently received initiations with Buy ratings from prominent financial institutions, indicating positive outlooks for their future performance. Arcellx, Inc. (Nasdaq: ACLX) has been initiated with a Buy rating and a price t. Read more
EyePoint Pharma's YUTIQ Sale, Protalix's Milestone Achievement, and Walmart's Q1 Surpass Expectations: Pre-Market Update
May 18th, 2023
EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT) has announced a definitive agreement for the sale of YUTIQ, their fluocinolone acetonide intravitreal implant used in the treatment of chronic non-infectious uveitis affecting the posterior segment of the. Read more
Q1 2023 Earnings Report: KE Holdings and Bath & Body Works Exceed Expectations, Sociedad Química y Minera de Chile Falls Short; Revvity Inks Licensing Deal with AstraZeneca
May 18th, 2023
KE Holdings Inc. (NYSE: BEKE) reported better-than-expected adjusted earnings per share (EPS) for the first quarter of 2023. The company's adjusted EPS stood at $0.43, surpassing the consensus estimate of $0.23. In pre-market trading, $BEKE . Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026January 13th, 2026Wall Street Eyes Bank of America, Wells Fargo, Citi Ahead of Earnings
January 11th, 2026
Member Login